| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Scholar Rock Holding Corporation (SRRK) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. SRRK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.37M | $301.38M | - | |
| CEO | 1.54M | $72.97M | - | |
| COO | 620.1K | $29.35M | - | |
| Pres | 595.8K | $28.20M | - | |
| CFO | 583.2K | $27.60M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2025 | Backstrom Jay T. | Chief Executive Officer | Sell | 18,372 | $36.83 | $676,622.39 | -5.6% | -18.4% | +27.1% | |
| Jan 16, 2025 | Marantz Jing L. | Chief Medical Officer | Sell | 5,655 | $44.20 | $249,935.17 | -7.8% | -32.2% | +2.4% | |
| Jan 16, 2025 | Sacco Tracey | Chief Commercial Officer | Sell | 3,890 | $44.20 | $171,927.11 | -7.9% | -32.2% | +2.4% | |
| Jan 16, 2025 | Qatanani Mo | Chief Scientific Officer | Sell | 7,347 | $44.20 | $324,716.83 | -5.1% | -32.2% | +2.4% | |
| Jan 16, 2025 | Parlavecchio Caryn | CHRO | Sell | 6,434 | $44.20 | $284,364.78 | -4.2% | -32.2% | +2.4% | |
| Jan 16, 2025 | Backstrom Jay T. | Chief Executive Officer | Sell | 22,308 | $44.20 | $985,951.14 | -6.3% | -32.2% | +2.4% | |
| Jan 16, 2025 | Myles Edward H57 | COO &CFO | Sell | 12,539 | $44.20 | $554,188.69 | -7.8% | -32.2% | +2.4% | |
| Jan 16, 2025 | Ho Junlin | General Counsel | Sell | 9,039 | $44.20 | $399,498.49 | -4.4% | -32.2% | +2.4% | |
| Dec 10, 2024 | Invus Public Equities, L.P.78 | 10% Owner | Sell | 1,600,000 | $41.65 | $66,640,000.00 | -14.7% | -21.0% | +1.2% | |
| Nov 25, 2024 | Invus Public Equities, L.P.78 | 10% Owner | Sell | 409,433 | $38.49 | $15,757,638.99 | -0.7% | -1.5% | +9.9% |